2011
DOI: 10.1016/j.idc.2011.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Colony-Stimulating Factors in the Prevention and Management of Infectious Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0
1

Year Published

2012
2012
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 89 publications
0
13
0
1
Order By: Relevance
“…G-CSF is also used to prevent or shorten neutropenia in chemotherapy-induced or primary congenital neutropenia [42], and mobilize hematopoietic stem cells to peripheral blood for transplantation [43]. Probably because of the anti-apoptotic and anti-inflammatory effects, G-CSF has also been used to treat nonhematopoietic targets including cerebral ischemia [44], spinal cord ischemia [45], infarct heart [46], and end stage liver disease [47].…”
Section: Discussionmentioning
confidence: 99%
“…G-CSF is also used to prevent or shorten neutropenia in chemotherapy-induced or primary congenital neutropenia [42], and mobilize hematopoietic stem cells to peripheral blood for transplantation [43]. Probably because of the anti-apoptotic and anti-inflammatory effects, G-CSF has also been used to treat nonhematopoietic targets including cerebral ischemia [44], spinal cord ischemia [45], infarct heart [46], and end stage liver disease [47].…”
Section: Discussionmentioning
confidence: 99%
“…Some authors have reported enhancement of neutrophil functions in terms of phagocytosis, superoxide anion generation, expression of CD11b/CD18 and bacterial killing (39–42), while others report reduced chemotaxis and altered expression of surface markers (4345). In general, treatment with the non-pegylated forms of rG-CSF has been shown to result in a modest decrease in the incidence of febrile neutropenia, with no significant impact on overall survival (46). Few studies have been conducted with pegfilgrastim to assess neutrophil function.…”
Section: Discussionmentioning
confidence: 99%
“…GM-CSF has recently been ascribed a role in immunity against pathogens via its action in stimulating production of granulocytes and monocytes/macrophages, as well as dendritic cell subsets [32]. GM-CSF enhances innate host defenses against microbial pathogens, and increases absolute numbers of circulating innate immune effector cells by accelerating bone marrow production and maturation [33]. As GM-CSF acts on bone marrow cells via hematopoiesis, its activity in our inflammation model implies that GM-CSF, and possibly other genes, may be at work locally in the bulla bone/bone marrow of the ear.…”
Section: Discussionmentioning
confidence: 99%